Rapport Therapeutics (RAPP) Stock Chart & Stock Price History $18.07 +0.21 (+1.18%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Rapport Therapeutics Stock Price Performance 5 Day Performance-2.64%1 Month Performance-19.76%3 Month Performance-14.88% Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address What most folks don’t know about oil (BIG missed opportunity) (Ad)$1 Trillion… That’s how much Big Tech is set to spend on AI investment in the coming months—according to Goldman Sachs. This investment is driving an A.I. boom that’s being felt across many industries… Including a specific group of energy tickers since A.I. data centers use a massive amount of power. One of those tickers is CEG, up nearly 600% in the last 3 years… Combined with the upcoming presidential election, we have the recipe for a major shakeup in the market. You see, each time the U.S. elects a new president, one overlooked part of the energy sector tends to see a big move. Fact is… this energy niche is BOOMING.And expects this underappreciated niche to continue rallying well into 2026. RAPP Stock Chart for Saturday, December, 21, 2024 RAPP Chart by TradingView Rapport Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$17.86$18.07+1.18%$19.08$17.52527,558 shs$660.93 million12/19/2024$18.83$17.86-5.15%$19.25$17.50130,393 shs$653.25 million12/18/2024$19.07$18.83-1.26%$20.25$18.44135,824 shs$688.73 million12/17/2024$18.56$19.07+2.75%$19.86$18.29110,000 shs$697.58 million12/16/2024$18.77$18.56-1.12%$19.98$18.14114,595 shs$678.93 million12/13/2024$19.01$18.77-1.26%$18.88$17.79142,072 shs$686.61 million Get the Latest News and Ratings for RAPP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$20.25$19.01-6.12%$20.25$18.79106,290 shs$695.31 million12/11/2024$20.50$20.25-1.22%$20.62$19.67370,026 shs$740.66 million12/10/2024$20.53$20.50-0.15%$21.15$19.76123,616 shs$749.81 million12/09/2024$20.46$20.53+0.34%$21.86$20.21110,052 shs$750.99 million12/06/2024$20.27$20.46+0.94%$20.59$19.8692,397 shs$748.35 million12/05/2024$21.56$20.27-5.98%$22.16$19.87116,996 shs$741.48 million12/04/2024$20.02$21.56+7.69%$21.76$19.44131,794 shs$788.67 million12/03/2024$24.00$20.02-16.58%$24.49$19.51165,247 shs$732.33 million12/02/2024$22.84$24.00+5.08%$24.17$22.8896,588 shs$877.82 million11/29/2024$22.39$22.84+2.01%$23.20$21.9030,110 shs$835.49 million11/28/2024$22.39$22.39$23.95$22.0753,905 shs$818.94 million11/27/2024$22.34$22.39+0.22%$23.95$22.0753,895 shs$819.03 million11/26/2024$22.33$22.34+0.04%$23.07$22.00119,453 shs$817.20 million11/25/2024$23.09$22.33-3.29%$24.12$21.73269,513 shs$816.83 million11/22/2024$22.52$23.09+2.53%$23.36$22.6064,257 shs$844.63 million11/21/2024$22.19$22.52+1.49%$23.44$21.89102,132 shs$823.78 million11/20/2024$22.28$22.19-0.40%$22.60$21.98153,963 shs$811.62 million Related Companies SWTX Stock Chart ZLAB Stock Chart VCEL Stock Chart GMTX Stock Chart KYMR Stock Chart VERA Stock Chart BHC Stock Chart ARWR Stock Chart DYN Stock Chart HCM Stock Chart Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RAPP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RAPP Stock Alerts